Crossmark

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials

Crossref DOI link: https://doi.org/10.1136/bmjresp-2016-000148

Published Online: 2016-12-08

Published Print: 2016-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

McGarvey, Lorcan

Morice, Alyn H

Smith, Jaclyn A

Birring, Surinder S

Chuecos, Ferran

Seoane, Beatriz

Jarreta, Diana
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00891462 at ClinicalTrials.gov

Documents that mention this clinical trial

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
https://doi.org/10.1136/bmjresp-2016-000148

nct01001494 at ClinicalTrials.gov

Documents that mention this clinical trial

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
https://doi.org/10.1136/bmjresp-2016-000148

nct01462929 at ClinicalTrials.gov

Documents that mention this clinical trial

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
https://doi.org/10.1136/bmjresp-2016-000148